Related references
Note: Only part of the references are listed.Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ben M. Eyck et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
Ben M. Eyck et al.
TRIALS (2021)
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study
Willemieke P. M. Dijksterhuis et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
Karama Asleh et al.
CLINICAL CANCER RESEARCH (2020)
z Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
Charlotte Stroes et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation
Patricia P. Reis et al.
SCIENTIFIC REPORTS (2020)
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests
Stephan Wenzel Jahn et al.
BRITISH JOURNAL OF CANCER (2020)
A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts
S. J. M. Hoefnagel et al.
PLOS ONE (2020)
Benchmarking of cell type deconvolution pipelines for transcriptomics data
Francisco Avila Cobos et al.
NATURE COMMUNICATIONS (2020)
The Correlation of Magee Equations™ and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer
Atilla Soran et al.
EUROPEAN JOURNAL OF BREAST HEALTH (2020)
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
Jan Bornschein et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK.
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
Tomaz Makovec
RADIOLOGY AND ONCOLOGY (2019)
Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing
Karen Chiam et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
Bo Jan Noordman et al.
BMC CANCER (2018)
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Bo Jan Noordman et al.
LANCET ONCOLOGY (2018)
The dynamics of HER2 status in esophageal adenocarcinoma
Aafke Creemers et al.
Oncotarget (2018)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy
Mian Xi et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Taxane anticancer agents: a patent perspective
Iwao Ojima et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?
Hans Fuchs et al.
GASTRIC CANCER (2016)
Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study
Elfriede Bollschweiler et al.
ANNALS OF SURGERY (2016)
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Joel H. Rubenstein et al.
GASTROENTEROLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
Jules Lin et al.
ONCOTARGET (2015)
Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern
E. Versteijne et al.
DISEASES OF THE ESOPHAGUS (2015)
Assessment of Tumor Regression of Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy
Eva Karamitopoulou et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Vera Oppedijk et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies
Kazuki Sudo et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis
Tomoko Ohashi et al.
MOLECULAR CANCER RESEARCH (2013)
Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation
Takashi Taketa et al.
ONCOLOGY (2013)
Targeting therapy for esophageal cancer in patients aged 70 and over
Heidi Furlong et al.
JOURNAL OF GERIATRIC ONCOLOGY (2013)
Stage for Stage Comparison of Recurrence Patterns after Definitive Chemoradiotherapy or Surgery for Oesophageal Carcinoma
T. D. Reid et al.
CLINICAL ONCOLOGY (2012)
5-Fluorouracil derivatives: a patent review
Pablo Alvarez et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation
Takashi Taketa et al.
ONCOLOGY (2012)
Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer
E. F. W. Courrech Staal et al.
BRITISH JOURNAL OF SURGERY (2010)
Tackling the widespread and critical impact of batch effects in high-throughput data
Jeffrey T. Leek et al.
NATURE REVIEWS GENETICS (2010)
Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
Soo Mi Kim et al.
PLOS ONE (2010)
TaqMan (R) low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer
Ute Warnecke-Eberz et al.
PHARMACOGENOMICS (2010)
CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer
Ralf Metzger et al.
PHARMACOGENOMICS (2010)
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers
Amel Saadi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quantitative Analysis of Survivin RNA Expression in Blood as a Non-Invasive Predictor of Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
Peter Grimminger et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus
Jan Brabender et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000-05): Preliminary results
O. Bouche et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:: FFCD 9102
Laurent Bedenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer
H Xi et al.
CLINICAL CANCER RESEARCH (2005)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer
F Miyazono et al.
BRITISH JOURNAL OF CANCER (2004)
High specificity of quantitative excision repair Cross-Complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer
U Warnecke-Eberz et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
